01-08-2024 |
PM |
|
AUPH |
Aurinia Pharmaceuticals Inc |
803.77 |
0.02 |
0.01 |
-0.08 |
Aurinia Pharma beats Q2 estimates, narrows FY revenue guidance [8/1/2024 6:05 AM] |
5.61 |
-0.27 (-4.68%) |
5.76 |
-0.12 (-2.04%) |
4.71 - 11.52 |
1,375,500 |
1,520,000 |
18,368 |
|
|
02-05-2024 |
PM |
|
AUPH |
Aurinia Pharmaceuticals Inc |
724.53 |
-0.03 |
-0.17 |
-0.18 |
Aurinia Pharma GAAP EPS of -$0.07 beats by $0.07, revenue of $50.3M beats by $3.23M [5/2/2024 6:09 AM] |
5.16 |
-0.04 (-0.87%) |
5.54 |
0.34 (6.54%) |
4.71 - 12.43 |
3,109,969 |
1,330,000 |
38,425 |
|
|
15-02-2024 |
PM |
|
AUPH |
Aurinia Pharmaceuticals Inc |
1,120 |
-0.19 |
-0.18 |
-0.18 |
Aurinia Pharma GAAP EPS of -$0.19 misses by $0.03, revenue of $45.1M misses by $0.06M [2/15/2024 6:02 AM] |
6.01 |
-1.96 (-24.59%) |
6.01 |
-1.96 (-24.59%) |
5.50 - 12.43 |
17,337,193 |
1,800,000 |
1,877,720 |
|
|
02-11-2023 |
PM |
|
AUPH |
Aurinia Pharmaceuticals Inc |
1,050 |
-0.09 |
-0.17 |
-0.06 |
Aurinia Pharma GAAP EPS of -$0.09 beats by $0.08, revenue of $54.52M beats by $16.02M [11/2/2023 6:02 AM] |
7.88 |
0.75 (10.52%) |
7.88 |
0.0 (0.00%) |
4.07 - 12.43 |
3,083,202 |
1,410,000 |
42,124 |
|
|
03-08-2023 |
PM |
|
AUPH |
Aurinia Pharmaceuticals Inc |
1,490 |
-0.08 |
-0.20 |
-0.25 |
Aurinia Pharma GAAP EPS of -$0.08 beats by $0.11, revenue of $41.49M beats by $3.98M [8/3/2023 6:02 AM] |
10.56 |
0.43 (4.24%) |
10.25 |
0.12 (1.18%) |
4.07 - 12.43 |
7,755,876 |
2,910,000 |
387,723 |
|
|
04-05-2023 |
PM |
6:00 AM ET (May 4) |
AUPH |
Aurinia Pharmaceuticals Inc |
1,660 |
-0.18 |
-0.23 |
-0.27 |
Aurinia Pharma GAAP EPS of -$0.18 beats by $0.04, revenue of $34.41M beats by $6.29M [5/4/2023 6:03 AM] |
11.33 |
-0.36 (-3.08%) |
11.91 |
0.22 (1.88%) |
4.07 - 13.41 |
4,600,357 |
3,310,000 |
260,383 |
|
|
28-02-2023 |
PM |
6:00 AM ET (Feb 28) |
AUPH |
Aurinia Pharmaceuticals Inc |
1,120 |
-0.18 |
-0.26 |
-0.25 |
Aurinia Pharma reports mixed Q4 earnings; reaffirms FY23 outlook [2/28/2023 6:01 AM] |
9.06 |
0.73 (8.82%) |
8.29 |
-0.04 (-0.48%) |
4.07 - 13.41 |
5,182,757 |
2,520,000 |
29,612 |
|
|
03-11-2022 |
PM |
6:00 AM ET (Nov 3) |
AUPH |
Aurinia Pharmaceuticals Inc |
1,140 |
-0.06 |
-0.17 |
-0.39 |
Aurinia Pharma GAAP EPS of -$0.06 beats by $0.13, revenue of $55.78M beats by $19.38M [11/3/2022 6:05 AM] |
5.18 |
-2.42 (-31.87%) |
5.50 |
-2.11 (-27.73%) |
5.03 - 33.97 |
10,578,210 |
3,030,000 |
1,479,778 |
|
|
04-08-2022 |
PM |
6:00 AM ET (Aug 4) |
AUPH |
Aurinia Pharmaceuticals Inc |
1,470 |
-0.25 |
-0.22 |
-0.37 |
Aurinia Pharma GAAP EPS of -$0.25 misses by $0.03, revenue of $28.2M beats by $1.16M [8/4/2022 6:01 AM] |
8.52 |
0.02 (0.24%) |
8.59 |
0.09 (1.06%) |
7.70 - 33.97 |
7,456,442 |
3,340,000 |
85,861 |
|
|
10-05-2022 |
PM |
6:00 AM ET (May 10) |
AUPH |
Aurinia Pharmaceuticals Inc |
1,440 |
-0.27 |
-0.26 |
-0.40 |
Aurinia Pharma GAAP EPS of -$0.27 in-line, revenue of $21.63M beats by $2.39M [5/10/2022 6:02 AM] |
11.23 |
2.28 (25.54%) |
9.61 |
0.66 (7.43%) |
8.86 - 33.97 |
4,401,304 |
2,910,233 |
103,119 |
|
|
28-02-2022 |
PM |
6:00 AM ET (Feb 28) |
AUPH |
Aurinia Pharmaceuticals Inc |
2,070 |
-0.25 |
-0.26 |
-0.05 |
Aurinia Pharma GAAP EPS of -$0.25 beats by $0.02, revenue of $23.4M beats by $1.57M [2/28/2022 6:00 AM] |
12.39 |
-3.85 (-23.71%) |
11.68 |
-4.56 (-28.08%) |
9.72 - 33.97 |
19,407,009 |
2,910,000 |
1,904,004 |
|
|
03-11-2021 |
PM |
8:00 AM ET (Nov 3) |
AUPH |
Aurinia Pharmaceuticals Inc |
4,190 |
-0.39 |
-0.31 |
-0.28 |
Aurinia Pharma EPS misses by $0.06, beats on revenue [11/3/2021 6:11 AM] |
30.26 |
-1.74 (-5.44%) |
30.20 |
-1.80 (-5.62%) |
9.72 - 33.97 |
7,356,537 |
7,310,000 |
467,649 |
|
|
05-08-2021 |
AH |
4:05 PM ET (Aug 5) |
AUPH |
Aurinia Pharmaceuticals Inc |
1,740 |
-0.37 |
-0.35 |
-0.26 |
Aurinia Pharma EPS misses by $0.01, beats on revenue [8/5/2021 4:16 PM] |
14.36 |
2.65 (22.63%) |
13.16 |
1.45 (12.38%) |
9.72 - 20.50 |
11,151,253 |
5,580,000 |
122,800 |
|
|
06-05-2021 |
AH |
4:00 PM ET (May 6) |
AUPH |
Aurinia Pharmaceuticals Inc |
1,610 |
-0.40 |
-0.35 |
-0.15 |
Aurinia Pharma EPS misses by $0.02, misses on revenue [5/6/2021 4:07 PM] |
10.12 |
-2.21 (-17.95%) |
10.67 |
-1.67 (-13.53%) |
10.03 - 20.50 |
13,157,043 |
5,010,000 |
1,022,448 |
|
|
24-02-2021 |
AH |
4:00 PM ET (Feb 24) |
AUPH |
Aurinia Pharmaceuticals Inc |
2,020 |
-0.05 |
-0.31 |
-0.29 |
Aurinia Pharma EPS beats by $0.15, beats on revenue [2/24/2021 4:07 PM] |
14.60 |
0.02 (0.14%) |
15.00 |
0.42 (2.88%) |
9.83 - 20.50 |
6,039,395 |
3,110,710 |
298,675 |
|
|
10-11-2020 |
AH |
|
AUPH |
Aurinia Pharmaceuticals Inc |
1,741 |
-0.28 |
-0.22 |
0.00 |
Aurinia Pharma EPS misses by $0.05, misses on revenue [11/10/2020 4:29 PM] |
13.25 |
-0.32 (-2.36%) |
13.77 |
0.20 (1.47%) |
4.90 - 21.93 |
1,810,047 |
1,646,203 |
6,849 |
|
|
11-08-2020 |
AH |
4:00 PM ET (Aug 11) |
AUPH |
Aurinia Pharmaceuticals Inc |
1,850 |
-0.26 |
-0.23 |
-0.17 |
Aurinia Pharma EPS misses by $0.03, revenue in-line [8/11/2020 4:04 PM] |
14.17 |
0.17 (1.21%) |
13.63 |
-0.37 (-2.64%) |
3.52 - 21.93 |
930,108 |
1,564,751 |
89,324 |
|
|
14-05-2020 |
AH |
4:00 PM ET (May 14) |
AUPH |
Aurinia Pharmaceuticals Inc |
2,000 |
-0.15 |
-0.20 |
-0.16 |
Aurinia Pharma EPS beats by $0.12, misses on revenue [5/14/2020 4:07 PM] |
17.16 |
-0.24 (-1.38%) |
17.13 |
-0.03 (-0.17%) |
3.52 - 21.93 |
1,311,086 |
1,093,498 |
9,045 |
|
|